4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Hyperactivity, Motor in 7 studies
4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.
Excerpt | Relevance | Reference |
---|---|---|
"Several clinical reports have suggested that the mirtazapine-induced augmentation of risperidone activity may effectively improve the positive, negative and some cognitive symptoms of schizophrenia." | 7.78 | Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice. ( Rogóż, Z, 2012) |
"Several clinical reports have suggested that the mirtazapine-induced augmentation of risperidone activity may effectively improve the positive, negative and some cognitive symptoms of schizophrenia." | 3.78 | Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice. ( Rogóż, Z, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, G | 1 |
Cheng, J | 1 |
McCorvy, JD | 1 |
Lorello, PJ | 1 |
Caldarone, BJ | 1 |
Roth, BL | 1 |
Kozikowski, AP | 1 |
Rogóż, Z | 1 |
Fox, MA | 1 |
Panessiti, MG | 1 |
Hall, FS | 1 |
Uhl, GR | 1 |
Murphy, DL | 1 |
Pałucha-Poniewiera, A | 1 |
Kłodzińska, A | 1 |
Stachowicz, K | 1 |
Tokarski, K | 1 |
Hess, G | 1 |
Schann, S | 1 |
Frauli, M | 1 |
Neuville, P | 1 |
Pilc, A | 1 |
McFarland, K | 1 |
Price, DL | 1 |
Bonhaus, DW | 1 |
Filip, M | 1 |
Bubar, MJ | 1 |
Cunningham, KA | 1 |
Siuciak, JA | 1 |
Chapin, DS | 1 |
McCarthy, SA | 1 |
Guanowsky, V | 1 |
Brown, J | 1 |
Chiang, P | 1 |
Marala, R | 1 |
Patterson, T | 1 |
Seymour, PA | 1 |
Swick, A | 1 |
Iredale, PA | 1 |
7 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Hyperactivity, Motor
Article | Year |
---|---|
Discovery of N-Substituted (2-Phenylcyclopropyl)methylamines as Functionally Selective Serotonin 2C Receptor Agonists for Potential Use as Antipsychotic Medications.
Topics: Animals; Antipsychotic Agents; Benzylamines; beta-Arrestins; Cyclopropanes; HEK293 Cells; Humans; Hy | 2017 |
Effect of co-treatment with mirtazapine and risperidone in animal models of the positive symptoms of schizophrenia in mice.
Topics: Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Dextroamphetamine; Disease Models, An | 2012 |
An evaluation of the serotonin system and perseverative, compulsive, stereotypical, and hyperactive behaviors in dopamine transporter (DAT) knockout mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Autoreceptors; Brain; Compulsive Beha | 2013 |
Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Cyclopentanes; Disease M | 2008 |
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System S | 2011 |
Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses.
Topics: Amphetamines; Animals; Cocaine; Drug Interactions; Fluorobenzenes; Hyperkinesis; Indoles; Male; Phen | 2004 |
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Topics: Amphetamines; Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Dextro | 2007 |